Company press releases

Displaying 1 - 44 of 44 results
Released Company Title Industry Topic
28 Sep 2023
09:45 CEST 		MITHRA Mithra prices private placement to raise EUR 20 million in equity 20103015 Pharmaceuticals Corporate life
28 Sep 2023
09:42 CEST 		MITHRA Mithra Financial Results for First-Half 2023 20103015 Pharmaceuticals Commercial results
27 Sep 2023
07:00 CEST 		MITHRA Mithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen at NAMS 2023 20103015 Pharmaceuticals -
26 Sep 2023
07:00 CEST 		MITHRA Mithra Financial Results for First-Half 2023 20103015 Pharmaceuticals -
22 Sep 2023
13:30 CEST 		MITHRA Mithra présentera ses résultats financiers du premier semestre 2023 à ses investisseurs lors d'une conférence web le 26 septembre à 14 h 00 CET 20103015 Pharmaceuticals -
21 Sep 2023
17:55 CEST 		MITHRA Information on the total number of voting rights (denominator) 20103015 Pharmaceuticals -
21 Sep 2023
17:55 CEST 		MITHRA Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CEST 20103015 Pharmaceuticals -
12 Sep 2023
17:45 CEST 		MITHRA Publication of a Transparency Notification Received from Armistice Capital, LLC 20103015 Pharmaceuticals -
12 Sep 2023
17:45 CEST 		MITHRA Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025 20103015 Pharmaceuticals -
11 Sep 2023
07:30 CEST 		MITHRA Letter to Shareholders and Corporate Update 20103015 Pharmaceuticals -
28 Aug 2023
17:45 CEST 		MITHRA Mithra completes EUR 20 million private placement in equity Update of total number of voting rights (denominator) 20103015 Pharmaceuticals -
24 Aug 2023
07:33 CEST 		MITHRA Mithra prices private placement to raise EUR 20 million in equity 20103015 Pharmaceuticals -
16 Jun 2023
08:55 CEST 		MITHRA Mithra Announces Sale of Shares in Mayne Pharma 20103015 Pharmaceuticals Other financial transaction
25 Apr 2023
16:06 CEST 		MITHRA Mithra Releases Invitation to its General Shareholders’ Meeting 20103015 Pharmaceuticals General meeting / Board Meeting
18 Apr 2023
11:16 CEST 		MITHRA Mithra releases 2022 Annual Report 20103015 Pharmaceuticals Corporate life
27 Sep 2022
09:40 CEST 		MITHRA Mithra 2022 Half Year Results 20103015 Pharmaceuticals Commercial results
17 Aug 2022
16:10 CEST 		MITHRA Mithra obtains funding for up to EUR 100 Million from existing investors and repurchases EUR 34.1 million of its convertible bonds due 2025 at a discount to par 20103015 Pharmaceuticals Other financial transaction
17 Aug 2022
15:39 CEST 		MITHRA Mithra Completes a EUR 23.5 Million Private Placement 20103015 Pharmaceuticals Change in Capital
17 Aug 2022
15:31 CEST 		MITHRA Mithra 2021 Full Year Results 20103015 Pharmaceuticals Commercial results
17 Aug 2022
15:22 CEST 		MITHRA Mithra résultats semestriels 2021 20103015 Pharmaceuticals Commercial results
17 Aug 2022
15:18 CEST 		MITHRA Mithra 2021 Half Year Results 20103015 Pharmaceuticals Commercial results
09 Mar 2021
07:54 CET 		MITHRA Mithra annonce ses résultats annuels 2020 20103015 Pharmaceuticals Commercial results
09 Mar 2021
07:52 CET 		MITHRA Mithra Reports Full Year 2020 Financial Results 20103015 Pharmaceuticals Commercial results
21 Jan 2021
15:30 CET 		MITHRA Mithra announces placement of EUR 125 million convertible bonds due 2025 20103015 Pharmaceuticals Other financial transaction
21 Jan 2021
15:26 CET 		MITHRA First Half 2020 financial report 20103015 Pharmaceuticals Corporate life
18 Jun 2020
20:45 CEST 		MITHRA Mithra Successfully Raises EUR 65.0 Million By Means of a Private Placement via an Accelerated Bookbuild Offering 20103015 Pharmaceuticals Change in Capital
18 Jun 2020
14:39 CEST 		MITHRA Mithra Launches Capital Increase By Means of a Private Placement via an Accelerated Bookbuild Offering and Provides an Update on its Financing Strategy 20103015 Pharmaceuticals Change in Capital
09 Mar 2020
07:30 CET 		MITHRA Mithra Reports Full Year 2019 Financial Results Pharmaceuticals Corporate life
09 Mar 2020
07:30 CET 		MITHRA Mithra annonce ses résultats annuels 2019 Pharmaceuticals Corporate life
10 Jan 2020
10:00 CET 		MITHRA E4 Paves the Road Towards a Revolutionary Era of Environmental Friendly Medicines Pharmaceuticals Trends / Analyses
01 Oct 2019
13:13 CEST 		MITHRA MITHRA SUCESSFULLY RENEGOTIATES EARNOUT PAYMENTS Pharmaceuticals Alliances and agreements
01 Oct 2019
13:12 CEST 		MITHRA MITHRA SIGNS LANDMARK CONTRACT FOR ESTELLE® IN THE UNITED STATES WITH MAYNE PHARMA Pharmaceuticals Alliances and agreements
19 Sep 2019
11:17 CEST 		MITHRA First half 2019 financial report Pharmaceuticals Corporate life
19 Sep 2019
07:49 CEST 		MITHRA Mithra Announces 2019 Half Year Results Pharmaceuticals Corporate life
08 Apr 2019
11:19 CEST 		MITHRA Mithra Releases 2018 Annual Report and Invitation to its General Shareholders’ Meeting Pharmaceuticals Corporate life
01 Mar 2019
08:43 CET 		MITHRA Mithra Reports 2018 Annual Results Pharmaceuticals Corporate life
30 Jan 2019
11:27 CET 		MITHRA Mithra annonce les premiers résultats positifs pour l’étude de phase III du contraceptif oral Estelle® aux États-Unis/Canada Pharmaceuticals -
22 Jan 2019
18:00 CET 		MITHRA MITHRA REPORTS 2017 ANNUAL RESULTS Pharmaceuticals Corporate life
22 Jan 2019
14:59 CET 		MITHRA Blockbuster potentiel en périménopause avec un nouveau produit candidat à base d’E4 et accélération du programme de Phase III pour Donesta Pharmaceuticals -
22 Jan 2019
14:55 CET 		MITHRA MITHRA ANNONCE SES RÉSULTATS SEMESTRIELS 2018 Pharmaceuticals -
21 Sep 2017
07:30 CEST 		MITHRA Mithra announces 2017 half year results Pharmaceuticals -
21 Sep 2017
07:30 CEST 		MITHRA Mithra publie ses résultats semestriels 2017 Pharmaceuticals -
28 Jun 2017
07:30 CEST 		MITHRA Mithra signe un accord de licence et d’approvisionnement exclusif avec Fuji Pharma pour Donesta® au Japon et en ASEAN Pharmaceuticals -
28 Jun 2017
07:30 CEST 		MITHRA Mithra Signs Exclusive License and Supply Agreement with Fuji Pharma for Donesta® in Japan and ASEAN Pharmaceuticals -